Hackensack Meridian Health is a clinical research site located in Edison, New Jersey, United States 88837.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Hackensack Meridian Health has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: Chronic Myelogenous Leukemia - Chronic Phase, Extensive Stage Small Cell Lung Cancer, Advanced, Metastatic Breast Cancer.
Sponsors: Novartis Pharmaceuticals, Saranas, Inc., Amryt Pharma.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hackensack Meridian Health has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hackensack Meridian Health has 5 clinical trials on record, with 3 currently active. Their work covers Chronic Myelogenous Leukemia - Chronic Phase, Extensive Stage Small Cell Lung Cancer, Advanced, Metastatic Breast Cancer.
Hackensack Meridian Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.